NEO Reports $187M Q1 Rev, $17M Net Loss, Raises FY26 Rev Guidance to $797-$803M, Launches RaDaR MRD Test, MolDX Coverage for PanTracer LBx
NeoGenomics, Inc. · SERVICES-TESTING LABORATORIES · Now $10.52
+4.7% in 3d after detection
Post-detection moves
1h
—
1d
-0.7%
3d
+4.7%
7d
+0.6%
30d
—
Get alerts like this in real time
Push notifications the moment a signal fires. No spam, no crypto, no fluff.
Download for iOS